A Study of DZD8586 in Adults With Primary Immune Thrombocytopenia (ITP) (TAI-SHAN11)

Clinical trial NCT07294365 · RECRUITING

Trial details

NCT number: NCT07294365
Sponsor: Dizal Pharmaceuticals
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Immune Thrombocytopenia (ITP)

Start date: 2026-01-15
Primary completion: 2027-07-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.